Drug Infusion System Market Is Anticipated to Grow at a Significant CAGR of 8.89% and Will Reach Upto USD 18.05 Billion by 2026, Estimates DelveInsight

Drug Infusion System Market

Drug Infusion System market is contemplated to surge in the coming years due to factors such as rising prevalence of chronic disorders such as cardiovascular disorders along with an increasing prevalence of cancers, there is an increase in the demand for Drug Infusion Systems observed, thus driving the growth of Drug Infusion System market.

 

DelveInsight’s Drug Infusion System Market Insights and Forecast report provides the current and forecast Drug Infusion System, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Drug Infusion System. 

 

Some of the essential takeaways from the Drug Infusion System Market report: 

According to DelveInsight analysis, North America is expected to dominate the overall Drug Infusion System Market during the forecast period.
Key pharma players proactively working in the Drug Infusion System market include B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, Arcomed Ag, Fresenius Kabi AG, Microport Scientific Corporation, Teleflex Incorporated., Smiths Medical, Baxter, Ivenix Inc, Terumo Corporation, Insulet Corporation., FLOWONIX MEDICAL INC, Intera Oncology and others.
As per DelveInsight estimates, the Global Drug Infusion System was valued at USD 10.83 billion in 2020 and is anticipated to grow at a massive CAGR of 8.89% during the forecast period from 2021 to 2026 and is also expected to reach USD 18.05 billion by 2026.
On August 09, 2021, Smiths Medical and Ivenix had announced their partnership pertaining to best-in-class infusion management technologies for improving the infusion delivery process.
On July 22, 2021, Innovative Health Sciences had announced the CE mark for syringe infusion system.
On April 26, 2021, Becton Dickinson and Company had announced FDA approval for BD Alaris System. 
On May 20, 2020, Baxter had announced the CE Marking and Australian regulatory approval for Evo IQ Syringe Infusion System.

 

To pick on the latest highlights related to the Drug Infusion System Market get the snapshot of the key highlights entailed in the Drug Infusion System Market report.

 

Drug Infusion System Overview

A Drug Infusion System is a medical pump that tends to deliver fluids, nutrients, and medications into the body of the patient in precise amounts. Drug Infusion System is used in hospitals, nursing homes, and in the homes. The Drug Infusion System tend to offer several advantages over manual administration of fluids, comprising of the ability for delivering fluids in very small volumes and the potential for delivering fluids at précised programming rates or automated intervals. It tends to deliver nutrients or medications, for instance, inulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. 

 

Interested in knowing how the Drug Infusion System Market will be growing by 2026? Click to get a snapshot of Drug Infusion System Market Landscape

 

Drug Infusion System Market Insight 

Geographically, the global Drug Infusion System market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America tends to lead the global Drug Infusion System market in the present scenario and is expected that it will continue to remain superior during the forecast period. However, the domination exhibited by North America will beconspicuously challenged by the European market. This domination in North America is attributed to the rising prevalence of chronic conditions such as cardiovascular disorders and type 2 diabetes, growing prevalence of obesity, favorable reimbursement policies, and the presence of all major key players in the North American market.

 

Understand more about the Drug Infusion System Market Landscape @ Drug Infusion System Analysis

 

Drug Infusion System Market Drivers and Barriers

The rising prevalence of cancers, rising prevalence of chronic conditions such as cardiovascular disorders and type 2 diabetesgrowing prevalence of obesity, there will be an increase in the demand of Drug Infusion System for the delivery of drugs, thereby leading to an increase in the Drug Infusion System market. In addition to that, recent development such as product launches, technologicallyadvanced Drug Infusion System is also driving the market growth further. Other aspects such as market development related to products, expansions, and mergers and acquisitions there will be a significant growth in Drug Infusion System market during the forecast period.

Drug Infusion System market had observed a period of stagnant growth owing to the outbreak of COVID-19 since 2020. Due to the COVID-19 pandemic situation, all the other forms of elective procedures were temporarily stopped in contrast to the COVID-19 affected patients that were given utmost priority. Other factors such as lockdown restrictions, patient reluctance to visit the hospitals and clinics, logistical restrictions, unavailability of medical devices and the closing down of manufacturing facilities can all be considered as potential setbacks for Drug Infusion System market.

 

Scope of the Drug Infusion System Market Report

Study Period: 2018-2026

Key Drug Infusion System Companies: B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, Arcomed Ag, Fresenius Kabi AG, Microport Scientific Corporation, Teleflex Incorporated., Smiths Medical, Baxter, Ivenix Inc, Terumo Corporation, Insulet Corporation., FLOWONIX MEDICAL INC, Intera Oncology and others.

Drug Infusion System Market Segmentation

By Product Type

Syringe Infusion Systems
Elastomeric Infusion Systems
Large-Volume Infusion Systems
Enteral Infusion Systems
PCA Infusion Systems
Insulin Pumps
Others

By Product Placement

External
Implantable

By Portability

Stationary
Ambulatory

By Application

Oncotherapy
Diabetes
Analgesia
Nutrition
Others

By End-User

Hospitals
Ambulatory Surgical Centers
Homecare Settings
Others

By Geography

North America
Europe
Asia-Pacific
Rest of the World

Delveinsight Analysis: The Drug Infusion System market is expected to grow at a CAGR of 8.89% and will reach 18.05 billion by 2026.

 

Table of Contents 

1

Drug Infusion System Market Report Introduction

2

Drug Infusion System Market Executive Summary

3

Regulatory and Patent Analysis

4

Drug Infusion System Market Key Factors Analysis

5

Drug Infusion System Market Porter’s Five Forces Analysis

6

COVID-19 Impact Analysis on Drug Infusion System Market 

7

Drug Infusion System Market Layout

8

Drug Infusion System Market Global Company Share Analysis – Key 3-5 Companies

9

Drug Infusion System Company and Product Profiles

10

Project Approach

11

KOL Views

12

DelveInsight Capabilities

13

Disclaimer & Contact Us

14

About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/drug-infusion-system-market